UBS Reviews JC Penney's Earnings, Maintains Sell Rating

In a report published Thursday, UBS analyst Michael Binetti reviewed J C Penney Company Inc JCP's first quarter results which were released on Wednesday.

According to Binetti, sales is the only line that will "definitely bolster confidence" in the long-term EBITDA recovery. The analyst added that JC Penney reported a first quarter same-stores sales gain of 3.4 percent which was below the company's guidance. Moreover, the company's full year same-store sales guidance growth of 4 to 5 percent is "well below" its 5.4 percent three-year target just 18 months into the turnaround.

Binetti also noted that JC Penney's traffic remains negative, and he sees further risk to long-term gains in conversion and ticket from the value-driven consumer. In addition, the analyst also sees risks to the company's 2017 $1.2 billion EBITDA target as the company has to consistently show progress towards the objectives.

JC Penney also faces "significant" financial leverage, according to Binetti. The company has a $415 million annual interest payment, the company has a "significantly" higher financial leverage versus its peers that could eventually limit growth investments or cause "outsized" P&L pressure in the event of a slowdown in the economy.

Finally, now that JC Penney has provided EBITDA targets for the first time ($600 million in fiscal 2015 and $900 million in fiscal 2016), shares should trade more like a department store than a recovery story. With that said, even assuming a $900 million EBITDA in 2016, a 7x multiple (in line with peers including Macy's Inc. M and Kohl's Corporation KSS) implies shares are valued at only $7.

Shares remain Sell rated with a price target raised to $7 from a previous $5.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: Analyst ColorPrice TargetAnalyst RatingsMichael BinettiretailersUBS
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!